Skip to Content


Please click on the protocol number for additional information.

Alliance A011202:
Comparison of Axillary Lymph Node Dissection With Axillary Radiation for Patients With Node-Positive Breast Cancer Treated With Chemotherapy

Alliance A011203: Tamoxifen Citrate or Z-Endoxifen Hydrochloride in Treating Patients with Locally Advanced or Metastatic, Estrogen Receptor-Positive, HER2-Negative Breast Cancer

BCCR: Breast Cancer Collaborative Registry

ECOG-ACRIN EAY131: NCI-MATCH: Targeted Therapy Directed by Genetic Testing in Treating Patients with Advanced Refractory Solid Tumors or Lymphomas

ECOG E1Z11: Anastrozole in Treating Aromatase Inhibitor Musculoskeletal Symptoms in Female Patients with Stage I-III Breast Cancer

ECOG-ACRIN E2112: Exemestane With or Without Entinostat in Treating Postmenopausal Patients With Recurrent Hormone Receptor-Positive Breast Cancer That Is Locally Advanced or Metastatic

NRG BR002: Standard of Care Therapy With or Without Stereotactic Radiosurgery and/or Surgery in Treating Patients With Limited Metastatic Breast Cancer

NRG BR003: Doxorubicin Hydrochloride and Cyclophosphamide Followed by Paclitaxel with or without Carboplatin in Treating Patients with Triple-Negative Breast Cancer

NSABP B-51: Standard or Comprehensive Radiation Therapy in Treating Patients With Early-Stage Breast Cancer Previously Treated With Chemotherapy and Surgery

NSABP B-52: Docetaxel, Carboplatin, Trastuzumab, and Pertuzumab With or Without Estrogen Deprivation in Treating Patients With Hormone Receptor-Positive, HER2-Positive Operable or Locally Advanced Breast Cancer

SWOG S1207: Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer